Skip to content

Clinical efficacy of using tiaozhou method combined with Q-switch 1064 nm clinical observation for the treatment of malasma

Clinical efficacy of using tiaozhou method combined with Q-switch 1064 nm clinical observation for the treatment of malasma

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17013658
Enrollment
Unknown
Registered
2017-12-03
Start date
2017-12-04
Completion date
Unknown
Last updated
2017-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

melasma

Interventions

experimental group:tiaozhou method combined with Q-switch 1 064 nm
control group: Q-switch 1 064 nm

Sponsors

Jiangsu Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: (1) combined with other pigmentary diseases (such as nevus Fusco-Caeruleuszygomaticu, Riehl melanosis,post-inflammatory pigmentation etc.); (2) patients who refuse to cooperate with doctors finish treatments; (3) patients had used laser and medicine for the treatment of chloasma during recent three months; (4) patients with mental disorders and behavioral disabilities, pregnant women and nursing mothers; (5) menstrual cycle is irregular.

Exclusion criteria

Exclusion criteria: (1) combined with other pigmentary diseases (such as nevus Fusco-Caeruleuszygomaticu, Riehl melanosis,post-inflammatory pigmentation etc.); (2) patients who refuse to cooperate with doctors finish treatments; (3) patients had used laser and medicine for the treatment of chloasma during recent three months; (4) patients with mental disorders and behavioral disabilities, pregnant women and nursing mothers; (5) menstrual cycle is irregular.

Design outcomes

Primary

MeasureTime frame
mMASI score;

Countries

China

Contacts

Public ContactJin Yu

Jiangsu Provincial Hospital of Traditional Chinese Medicine

190629408@qq.com+86 13770931953

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026